{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:07:11Z","timestamp":1778659631072,"version":"3.51.4"},"reference-count":172,"publisher":"Bentham Science Publishers Ltd.","issue":"40","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>In the field of precision and personalized medicine, the next generation sequencing\nmethod has begun to take an active place as genome-wide screening applications\nin the diagnosis and treatment of diseases. Studies based on the determination of\nthe therapeutic efficacy of personalized drug use in cancer treatment in the size of the\ntranscriptome and its extension, lncRNA, have been increasing rapidly in recent years.\nTargeting and\/or regulating noncoding RNAs (ncRNAs) consisting of long noncoding\nRNAs (lncRNAs) are promising strategies for cancer treatment. Within the scope of\nrapidly increasing studies in recent years, it has been shown that many natural agents obtained\nfrom biological organisms can potentially alter the expression of many lncRNAs\nassociated with oncogenic functions. Natural agents include effective small molecules\nthat provide anti-cancer effects and have been used as chemotherapy drugs or in combination\nwith standard anti-cancer drugs used in routine treatment. In this review, it was\naimed to provide detailed information about the potential of natural agents to regulate\nand\/or target non-coding RNAs and their mechanisms of action to provide an approach\nfor cancer therapy. The discovery of novel anti-cancer targets and subsequent development\nof effective drugs or combination strategies that are still needed for most cancers\nwill be promising for cancer treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673264372230919102758","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T07:33:33Z","timestamp":1699256013000},"page":"6672-6691","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy"],"prefix":"10.2174","volume":"31","author":[{"given":"Ay\u015fe","family":"Hale Alkan","sequence":"first","affiliation":[{"name":"Biotechnology Institute, Ankara University, Ke\u00e7i\u00f6ren, Ankara, Turkey"},{"name":"Department of Molecular Biology\nand Genetics, Faculty of Science, Bart\u0131n University, Bart\u0131n, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Ensoy","sequence":"additional","affiliation":[{"name":"Biotechnology Institute, Ankara University, Ke\u00e7i\u00f6ren, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demet","family":"Cansaran-Duman","sequence":"additional","affiliation":[{"name":"Biotechnology Institute, Ankara University, Ke\u00e7i\u00f6ren, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Stewart B. W.","year":"2014","unstructured":"Stewart B. W.; Wild C. P.;  World Cancer Report 2014  2014","journal-title":"World Cancer Report 2014"},{"key":"ref=2","unstructured":"Worldwide cancer data. World Cancer Research Fund International Available from:  https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data\/(accessed May 19, 2023)"},{"key":"ref=3","unstructured":"Worldwide cancer incidence statistics. Cancer Research UK Available from:  https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/worldwide-cancer\/incidence(accessed May 19, 2023)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"20503121211034366","DOI":"10.1177\/20503121211034366","volume":"9","author":"Debela D.T.","year":"2021","unstructured":"Debela D.T.; Muzazu S.G.Y.; Heraro K.D.; Ndalama M.T.; Mesele B.W.; Haile D.C.; Kitui S.K.; Manyazewal T.; New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med  2021,9,20503121211034366","journal-title":"SAGE Open Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"Bukowski K.","year":"2020","unstructured":"Bukowski K.; Kciuk M.; Kontek R.; Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci  2020,21(9),3233","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1559325820936161","DOI":"10.1177\/1559325820936161","volume":"18","author":"Yan L.","year":"2020","unstructured":"Yan L.; Shen J.; Wang J.; Yang X.; Dong S.; Lu S.; Nanoparticle-based drug delivery system: A patient-friendly chemotherapy for oncology. Dose Response  2020,18(3),1559325820936161","journal-title":"Dose Response"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"790589","DOI":"10.3389\/fonc.2021.790589","volume":"11","author":"Liu X.Y.","year":"2022","unstructured":"Liu X.Y.; Zhang Q.; Guo J.; Zhang P.; Liu H.; Tian Z.B.; Zhang C.P.; Li X.Y.; The role of circular rnas in the drug resistance of cancers. Front Oncol  2022,11,790589","journal-title":"Front Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.3390\/ijms19113533","volume":"19","author":"Lichota A.","year":"2018","unstructured":"Lichota A.; Gwozdzinski K.; Anti-cancer activity of natural compounds from plant and marine environment. Int J Mol Sci  2018,19(11),3533","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"Mansoori B.","year":"2017","unstructured":"Mansoori B.; Mohammadi A.; Davudian S.; Shirjang S.; Baradaran B.; The different mechanisms of cancer drug resistance: A brief review. Adv Pharm Bull  2017,7(3),339-348","journal-title":"Adv Pharm Bull"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.13040\/IJPSR.0975-8232.6(10).4103-12","volume":"6","author":"Greenwell M.","year":"2015","unstructured":"Greenwell M.; Rahman P.K.S.M.; Medicinal plants: Their use in anti-cancer treatment. Int J Pharm Sci Res  2015,6(11),4103-4112","journal-title":"Int J Pharm Sci Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel R.L.","year":"2019","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2019. CA Cancer J Clin  2019,69(1),7-34","journal-title":"CA Cancer J Clin"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10616-020-00430-7","volume":"72","author":"Cansaran-Duman D.","year":"2020","unstructured":"Cansaran-Duman D.; Tanman \u00dc.; Yang\u0131n S.; Atakol O.; The comparison of miRNAs that respond to anti-breast cancer drugs and usnic acid for the treatment of breast cancer. Cytotechnology  2020,72(6),855-872","journal-title":"Cytotechnology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.drudis.2022.02.015","volume":"27","author":"Beck H.","year":"2022","unstructured":"Beck H.; H\u00e4rter M.; Ha\u00df B.; Schmeck C.; Baerfacker L.; Small molecules and their impact in drug discovery: A perspective on the occasion of the 125 anniversary of the bayer chemical research laboratory. Drug Discov Today  2022,27(6),1560-1574","journal-title":"Drug Discov Today"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms19010263","volume":"19","author":"Seca A.","year":"2018","unstructured":"Seca A.; Pinto D.; Plant secondary metabolites as anti-cancer agents: Successes in clinical trials and therapeutic application. Int J Mol Sci  2018,19(1),263","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/1097-0142(196310)16:10<1302::AID-CNCR2820161011>3.0.CO;2-A","volume":"16","author":"Evans A. E.","year":"1963","unstructured":"Evans A. E.; Farber S.; Brunet S.; Marlano P. J.; Johnson W.; Vincristine in the treatment of acute leukemia in children. Cancer  1963,16,1302-1306","journal-title":"Cancer"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","volume":"25","author":"Weaver B.A.","year":"2014","unstructured":"Weaver B.A.; How Taxol\/paclitaxel kills cancer cells. Mol Biol Cell  2014,25(18),2677-2681","journal-title":"Mol Biol Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"Huang M.","year":"2021","unstructured":"Huang M.; Lu J.J.; Ding J.; Natural products in cancer therapy: Past, present and future. Nat Prod Bioprospect  2021,11(1),5-13","journal-title":"Nat Prod Bioprospect"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"694363","DOI":"10.3389\/fcell.2021.694363","volume":"9","author":"Sun G.","year":"2021","unstructured":"Sun G.; Rong D.; Li Z.; Sun G.; Wu F.; Li X.; Cao H.; Cheng Y.; Tang W.; Sun Y.; Role of small molecule targeted compounds in cancer: Progress, opportunities, and challenges. Front Cell Dev Biol  2021,9,694363","journal-title":"Front Cell Dev Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1039\/C8MD90019A","volume":"9","author":"Ngo H.X.","year":"2018","unstructured":"Ngo H.X.; Garneau-Tsodikova S.; What are the drugs of the future? MedChemComm  2018,9(5),757-758","journal-title":"MedChemComm"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"Zhong L.","year":"2021","unstructured":"Zhong L.; Li Y.; Xiong L.; Wang W.; Wu M.; Yuan T.; Yang W.; Tian C.; Miao Z.; Wang T.; Yang S.; Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal Transduct Target Ther  2021,6(1),201","journal-title":"Signal Transduct Target Ther"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euroneuro.2021.10.005","volume":"54","author":"Xicota L.","year":"2022","unstructured":"Xicota L.; De Toma I.; Maffioletti E.; Pisanu C.; Squassina A.; Baune B.T.; Potier M.C.; Stacey D.; Dierssen M.; Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders. Eur Neuropsychopharmacol  2022,54,41-53","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1124\/pr.120.019554","volume":"72","author":"Yu A.M.","year":"2020","unstructured":"Yu A.M.; Choi Y.H.; Tu M.J.; RNA drugs and RNA targets for small molecules: Principles, progress, and challenges. Pharmacol Rev  2020,72(4),862-898","journal-title":"Pharmacol Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"kuab063","DOI":"10.1093\/jimb\/kuab063","volume":"48","author":"Mollocana-Lara E.C.","year":"2021","unstructured":"Mollocana-Lara E.C.; Ni M.; Agathos S.N.; Gonzales-Zubiate F.A.; The infinite possibilities of RNA therapeutics. J Ind Microbiol Biotechnol  2021,48(9-10),kuab063","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11095-010-0105-y","volume":"27","author":"Li Y.","year":"2010","unstructured":"Li Y.; Kong D.; Wang Z.; Sarkar F.H.; Regulation of microRNAs by natural agents: An emerging field in chemoprevention and chemotherapy research. Pharm Res  2010,27(6),1027-1041","journal-title":"Pharm Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"612393","DOI":"10.3389\/fmed.2020.612393","volume":"7","author":"Qian Y.","year":"2020","unstructured":"Qian Y.; Shi L.; Luo Z.; Long non-coding RNAs in cancer: Implications for diagnosis, prognosis, and therapy. Front Med  2020,7,612393","journal-title":"Front Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"Arun G.","year":"2018","unstructured":"Arun G.; Diermeier S.D.; Spector D.L.; Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med  2018,24(3),257-277","journal-title":"Trends Mol Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fgene.2019.00478","volume":"10","author":"Hanna J.","year":"2019","unstructured":"Hanna J.; Hossain G.S.; Kocerha J.; The potential for microRNA therapeutics and clinical research. Front Genet  2019,10(MAY),478","journal-title":"Front Genet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.2147\/OTT.S178431","volume":"11","author":"Lu T.","year":"2018","unstructured":"Lu T.; Wang Y.; Chen D.; Liu J.; Jiao W.; Potential clinical application of lncRNAs in non-small cell lung cancer. OncoTargets Ther  2018,11,8045-8052","journal-title":"OncoTargets Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","volume":"28","author":"Chakraborty C.","year":"2021","unstructured":"Chakraborty C.; Sharma A.R.; Sharma G.; Lee S.S.; Therapeutic advances of miRNAs: A preclinical and clinical update. J Adv Res  2021,28,127-138","journal-title":"J Adv Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1083\/jcb.201208082","volume":"199","author":"Lindow M.","year":"2012","unstructured":"Lindow M.; Kauppinen S.; Discovering the first microRNA-targeted drug. J Cell Biol  2012,199(3),407-412","journal-title":"J Cell Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tips.2022.01.008","volume":"43","author":"Mercer T.R.","year":"2022","unstructured":"Mercer T.R.; Munro T.; Mattick J.S.; The potential of long noncoding RNA therapies. Trends Pharmacol Sci  2022,43(4),269-280","journal-title":"Trends Pharmacol Sci"},{"key":"ref=32","first-page":"1354","volume":"9","author":"Jiang M-C.","year":"2019","unstructured":"Jiang M-C.; Ni J-J.; Cui W-Y.; Wang B-Y.; Zhuo W.; Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res  2019,9(7),1354-1366","journal-title":"Am J Cancer Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","volume":"1008","author":"Jarroux J.","year":"2017","unstructured":"Jarroux J.; Morillon A.; Pinskaya M.; History, discovery, and classification of lncRNAs. Adv Exp Med Biol  2017,1008,1-46","journal-title":"Adv Exp Med Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ncrna4030017","volume":"4","author":"Mattick J.S.","year":"2018","unstructured":"Mattick J.S.; The state of long non-coding RNA Biology. Noncoding RNA  2018,4(3),17","journal-title":"Noncoding RNA"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1101\/gr.131037.111","volume":"22","author":"Clark M.B.","year":"2012","unstructured":"Clark M.B.; Johnston R.L.; Inostroza-Ponta M.; Fox A.H.; Fortini E.; Moscato P.; Dinger M.E.; Mattick J.S.; Genome-wide analysis of long noncoding RNA stability. Genome Res  2012,22(5),885-898","journal-title":"Genome Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/cancers14030755","volume":"14","author":"Orafidiya F.","year":"2022","unstructured":"Orafidiya F.; Deng L.; Bevan C.L.; Fletcher C.E.; Crosstalk between long non coding RNAs, microRNAs and DNA damage repair in prostate cancer: New therapeutic opportunities? Cancers  2022,14(3),755","journal-title":"Cancers"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","volume":"13","author":"Zhang A.","year":"2015","unstructured":"Zhang A.; Zhao J.C.; Kim J.; Fong K.; Yang Y.A.; Chakravarti D.; Mo Y.Y.; Yu J.; LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep  2015,13(1),209-221","journal-title":"Cell Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/ng.2771","volume":"45","author":"Prensner J.R.","year":"2013","unstructured":"Prensner J.R.; Iyer M.K.; Sahu A.; Asangani I.A.; Cao Q.; Patel L.; Vergara I.A.; Davicioni E.; Erho N.; Ghadessi M.; Jenkins R.B.; Triche T.J.; Malik R.; Bedenis R.; McGregor N.; Ma T.; Chen W.; Han S.; Jing X.; Cao X.; Wang X.; Chandler B.; Yan W.; Siddiqui J.; Kunju L.P.; Dhanasekaran S.M.; Pienta K.J.; Feng F.Y.; Chinnaiyan A.M.; The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI\/SNF complex. Nat Genet  2013,45(11),1392-1398","journal-title":"Nat Genet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.ymthe.2017.04.016","volume":"25","author":"Gu P.","year":"2017","unstructured":"Gu P.; Chen X.; Xie R.; Han J.; Xie W.; Wang B.; Dong W.; Chen C.; Yang M.; Jiang J.; Chen Z.; Huang J.; Lin T.; lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5. Mol Ther  2017,25(8),1959-1973","journal-title":"Mol Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41586-018-0453-z","volume":"561","author":"Munschauer M.","year":"2018","unstructured":"Munschauer M.; Nguyen C.T.; Sirokman K.; Hartigan C.R.; Hogstrom L.; Engreitz J.M.; Ulirsch J.C.; Fulco C.P.; Subramanian V.; Chen J.; Schenone M.; Guttman M.; Carr S.A.; Lander E.S.; The NORAD lncRNA assembles a topoisomerase complex critical for genome stability. Nature  2018,561(7721),132-136","journal-title":"Nature"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"13479","DOI":"10.18632\/oncotarget.7266","volume":"7","author":"Yang C.","year":"2016","unstructured":"Yang C.; Wu D.; Gao L.; Liu X.; Jin Y.; Wang D.; Wang T.; Li X.; Competing endogenous RNA networks in human cancer: Hypothesis, validation, and perspectives. Oncotarget  2016,7(12),13479-13490","journal-title":"Oncotarget"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-0716-1170-8_5","author":"Alkan A.H.","year":"2022","unstructured":"Alkan A.H.; Akg\u00fcl B.; Endogenous MiRNA sponges. Methods Mol Biol  2022,91-104","journal-title":"Methods Mol Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/cells11010025","volume":"11","author":"Jia M.","year":"2021","unstructured":"Jia M.; Shi Y.; Xie Y.; Li W.; Deng J.; Fu D.; Bai J.; Ma Y.; Zuberi Z.; Li J.; Li Z.; WT1-AS\/IGF2BP2 axis is a potential diagnostic and prognostic biomarker for lung adenocarcinoma according to ceRNA network comprehensive analysis combined with experiments. Cells  2021,11(1),25","journal-title":"Cells"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.13237","volume":"103","author":"Cui Y.S.","year":"2019","unstructured":"Cui Y.S.; Song Y.P.; Fang B.J.; The role of long non-coding RNAs in multiple myeloma. Eur J Haematol  2019,103(1),3-9","journal-title":"Eur J Haematol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e1007540","DOI":"10.1371\/journal.pcbi.1007540","volume":"15","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Chen S.; Chen L.; Wang Y.; Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs. PLOS Comput Biol  2019,15(12),e1007540","journal-title":"PLOS Comput Biol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","volume":"21","author":"Childs-Disney J.L.","year":"2022","unstructured":"Childs-Disney J.L.; Yang X.; Gibaut Q.M.R.; Tong Y.; Batey R.T.; Disney M.D.; Targeting RNA structures with small molecules. Nat Rev Drug Discov  2022,21(10),736-762","journal-title":"Nat Rev Drug Discov"},{"key":"ref=47","author":"Murray A.","year":"2021","unstructured":"Murray A.; Hearn J.; Turner S.; The emerging landscape of RNA-targeted small molecules.  Available from: https:\/\/www.alacrita.com\/whitepapers\/the-emerging-landscape-of-rna-targeted-small-molecules#:~:text=An%20emerging%20strategy%20to%20exploit,thus%20altering%20its%20conformational%20landscape.2021"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41388-019-1040-y","volume":"39","author":"Yousefi H.","year":"2020","unstructured":"Yousefi H.; Maheronnaghsh M.; Molaei F.; Mashouri L.; Reza Aref A.; Momeny M.; Alahari S.K.; Long noncoding RNAs and exosomal lncRNAs: Classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene  2020,39(5),953-974","journal-title":"Oncogene"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"Gupta R.A.","year":"2010","unstructured":"Gupta R.A.; Shah N.; Wang K.C.; Kim J.; Horlings H.M.; Wong D.J.; Tsai M.C.; Hung T.; Argani P.; Rinn J.L.; Wang Y.; Brzoska P.; Kong B.; Li R.; West R.B.; van de Vijver M.J.; Sukumar S.; Chang H.Y.; Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature  2010,464(7291),1071-1076","journal-title":"Nature"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.13642","volume":"109","author":"Sanchez Calle A.","year":"2018","unstructured":"Sanchez Calle A.; Kawamura Y.; Yamamoto Y.; Takeshita F.; Ochiya T.; Emerging roles of long non-coding RNA in cancer. Cancer Sci  2018,109(7),2093-2100","journal-title":"Cancer Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2010.06.040","volume":"142","author":"Huarte M.","year":"2010","unstructured":"Huarte M.; Guttman M.; Feldser D.; Garber M.; Koziol M.J.; Kenzelmann-Broz D.; Khalil A.M.; Zuk O.; Amit I.; Rabani M.; Attardi L.D.; Regev A.; Lander E.S.; Jacks T.; Rinn J.L.; A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell  2010,142(3),409-419","journal-title":"Cell"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1574892813666180226121819","volume":"13","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Tang L.; The application of lncRNAs in cancer treatment and diagnosis. Recent Patents Anti-cancer Drug Discov  2018,13(3),292-301","journal-title":"Recent Patents Anti-cancer Drug Discov"},{"key":"ref=53","author":"Hoon D. S. B.","year":"2016","unstructured":"Hoon D. S. B.; Lessard L.; Long Noncoding RNA (LncRNA) as a biomarker and therapeutic marker in cancer.  2016"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-biochem-062917-011942","volume":"87","author":"Lin J.","year":"2018","unstructured":"Lin J.; Zhou D.; Steitz T.A.; Polikanov Y.S.; Gagnon M.G.; Ribosome-targeting antibiotics: Modes of action, mechanisms of resistance, and implications for drug design. Annu Rev Biochem  2018,87(1),451-478","journal-title":"Annu Rev Biochem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-022-01230-6","volume":"15","author":"Zhao R.","year":"2022","unstructured":"Zhao R.; Fu J.; Zhu L.; Chen Y.; Liu B.; Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy. J Hematol Oncol  2022,15(1),14","journal-title":"J Hematol Oncol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"710738","DOI":"10.3389\/fmolb.2021.710738","volume":"8","author":"Feng R.","year":"2021","unstructured":"Feng R.; Patil S.; Zhao X.; Miao Z.; Qian A.; RNA therapeutics - Research and clinical advancements. Front Mol Biosci  2021,8,710738","journal-title":"Front Mol Biosci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"109997","DOI":"10.1016\/j.biopha.2020.109997","volume":"125","author":"Liang X.","year":"2020","unstructured":"Liang X.; Li D.; Leng S.; Zhu X.; RNA-based pharmacotherapy for tumors: From bench to clinic and back. Biomed Pharmacother  2020,125,109997","journal-title":"Biomed Pharmacother"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13148-019-0624-2","volume":"11","author":"Ren Y.","year":"2019","unstructured":"Ren Y.; Wang Y.; Zhang J.; Wang Q.; Han L.; Mei M.; Kang C.; Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2. Clin Epigenetics  2019,11(1),29","journal-title":"Clin Epigenetics"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1021\/acschembio.8b00827","volume":"13","author":"Li Y.","year":"2018","unstructured":"Li Y.; Disney M.D.; Precise small molecule degradation of a noncoding RNA identifies cellular binding sites and modulates an oncogenic phenotype. ACS Chem Biol  2018,13(11),3065-3071","journal-title":"ACS Chem Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.3390\/molecules24162930","volume":"24","author":"Kotha R.R.","year":"2019","unstructured":"Kotha R.R.; Luthria D.L.; Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules  2019,24(16),2930","journal-title":"Molecules"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pbiomolbio.2021.04.001","volume":"164","author":"Gowhari Shabgah A.","year":"2021","unstructured":"Gowhari Shabgah A.; Hejri Zarifi S.; Mazloumi Kiapey S.S.; Ezzatifar F.; Pahlavani N.; Soleimani D.; Mohammadian Haftcheshmeh S.; Mohammadi H.; Gholizadeh Navashenaq J.; Curcumin and cancer; are long non-coding RNAs missing link? Prog Biophys Mol Biol  2021,164,63-71","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"Gupta S.C.","year":"2013","unstructured":"Gupta S.C.; Patchva S.; Aggarwal B.B.; Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J  2013,15(1),195-218","journal-title":"AAPS J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","volume":"32","author":"Prasad S.","year":"2014","unstructured":"Prasad S.; Gupta S.C.; Tyagi A.K.; Aggarwal B.B.; Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv  2014,32(6),1053-1064","journal-title":"Biotechnol Adv"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8912961","volume":"2019","author":"Zhang Z.","year":"2019","unstructured":"Zhang Z.; Yi P.; Tu C.; Zhan J.; Jiang L.; Zhang F.; Curcumin inhibits ERK\/c-Jun expressions and phosphorylation against endometrial carcinoma. BioMed Res Int  2019,2019,1-13","journal-title":"BioMed Res Int"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3892\/etm.2018.6345","volume":"16","author":"Hu S.","year":"2018","unstructured":"Hu S.; Xu Y.; Meng L.; Huang L.; Sun H.; Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Exp Ther Med  2018,16(2),1266-1272","journal-title":"Exp Ther Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"111131","DOI":"10.1016\/j.fct.2020.111131","volume":"137","author":"Chen T.","year":"2020","unstructured":"Chen T.; Zhao L.; Chen S.; Zheng B.; Chen H.; Zeng T.; Sun H.; Zhong S.; Wu W.; Lin X.; Wang L.; The curcumin analogue WZ35 affects glycolysis inhibition of gastric cancer cells through ROS-YAP-JNK pathway. Food Chem Toxicol  2020,137,111131","journal-title":"Food Chem Toxicol"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819870781","volume":"18","author":"Yu H.","year":"2019","unstructured":"Yu H.; Xie Y.; Zhou Z.; Wu Z.; Dai X.; Xu B.; Curcumin regulates the progression of colorectal cancer via LncRNA NBR2\/AMPK pathway. Technol Cancer Res Treat  2019,18","journal-title":"Technol Cancer Res Treat"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.phymed.2018.03.022","volume":"42","author":"Esmatabadi M.J.D.","year":"2018","unstructured":"Esmatabadi M.J.D.; Motamedrad M.; Sadeghizadeh M.; Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells. Phytomedicine  2018,42,56-65","journal-title":"Phytomedicine"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fphar.2020.00847","volume":"11","author":"Shao J.","year":"2020","unstructured":"Shao J.; Shi C.J.; Li Y.; Zhang F.; Pan F.; Fu W.; Zhang J.; LincROR mediates the suppressive effects of curcumin on hepatocellular carcinoma through inactivating Wnt\/\u03b2-catenin signaling. Front Pharmacol  2020,11,847","journal-title":"Front Pharmacol"},{"key":"ref=70","first-page":"3429","volume":"12","author":"Xu F.","year":"2020","unstructured":"Xu F.; Ji Z.; He L.; Chen M.; Chen H.; Feng Q.; Dong B.; Yang X.; Jiang L.; Jin R.; Downregulation of LINC01021 by curcumin analog Da0324 inhibits gastric cancer progression through activation of p53. Am J Transl Res  2020,12(7),3429-3444","journal-title":"Am J Transl Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/biof.1399","volume":"44","author":"Truong V.L.","year":"2018","unstructured":"Truong V.L.; Jun M.; Jeong W.S.; Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors  2018,44(1),36-49","journal-title":"Biofactors"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/ijms20071523","volume":"20","author":"Breuss J.","year":"2019","unstructured":"Breuss J.; Atanasov A.; Uhrin P.; Resveratrol and its effects on the vascular system. Int J Mol Sci  2019,20(7),1523","journal-title":"Int J Mol Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1530\/ERC-13-0171","volume":"21","author":"Carter L.G.","year":"2014","unstructured":"Carter L.G.; D\u2019Orazio J.A.; Pearson K.J.; Resveratrol and cancer: Focus on in vivo evidence. Endocr Relat Cancer  2014,21(3),R209-R225","journal-title":"Endocr Relat Cancer"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnut.2016.00008","volume":"3","author":"Varoni E.M.","year":"2016","unstructured":"Varoni E.M.; Lo Faro A.F.; Sharifi-Rad J.; Iriti M.; anti-cancer molecular mechanisms of resveratrol. Front Nutr  2016,3,8","journal-title":"Front Nutr"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.blre.2018.07.001","volume":"33","author":"Espinoza J.L.","year":"2019","unstructured":"Espinoza J.L.; Kurokawa Y.; Takami A.; Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies. Blood Rev  2019,33,43-52","journal-title":"Blood Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"e26391","DOI":"10.1371\/journal.pone.0026391","volume":"6","author":"Rimbaud S.","year":"2011","unstructured":"Rimbaud S.; Ruiz M.; Piquereau J.; Mateo P.; Fortin D.; Veksler V.; Garnier A.; Ventura-Clapier R.; Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS One  2011,6(10),e26391","journal-title":"PLoS One"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.3390\/molecules25204649","volume":"25","author":"Pyo I.S.","year":"2020","unstructured":"Pyo I.S.; Yun S.; Yoon Y.E.; Choi J.W.; Lee S.J.; Mechanisms of aging and the preventive effects of resveratrol on age-related diseases. Molecules  2020,25(20),4649","journal-title":"Molecules"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9932218","volume":"2021","author":"Zhou D.D.","year":"2021","unstructured":"Zhou D.D.; Luo M.; Huang S.Y.; Saimaiti A.; Shang A.; Gan R.Y.; Li H.B.; Effects and mechanisms of resveratrol on aging and age-related diseases. Oxid Med Cell Longev  2021,2021,1-15","journal-title":"Oxid Med Cell Longev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/jcmm.17242","volume":"26","author":"Li T.","year":"2022","unstructured":"Li T.; Zhang X.; Cheng L.; Li C.; Wu Z.; Luo Y.; Zhou K.; Li Y.; Zhao Q.; Huang Y.; Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress. J Cell Mol Med  2022,26(8),2205-2217","journal-title":"J Cell Mol Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12032-021-01611-w","volume":"39","author":"Cesmeli S.","year":"2022","unstructured":"Cesmeli S.; Goker Bagca B.; Caglar H.O.; Ozates N.P.; Gunduz C.; Biray Avci C.; Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs. Med Oncol  2022,39(1),12","journal-title":"Med Oncol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.taap.2015.04.003","volume":"285","author":"Yang Q.","year":"2015","unstructured":"Yang Q.; Xu E.; Dai J.; Liu B.; Han Z.; Wu J.; Zhang S.; Peng B.; Zhang Y.; Jiang Y.; A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol  2015,285(2),79-88","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"103751","DOI":"10.1016\/j.critrevonc.2022.103751","volume":"176","author":"Singh D.","year":"2022","unstructured":"Singh D.; Gupta M.; Sarwat M.; Siddique H.R.; Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models. Crit Rev Oncol Hematol  2022,176,103751","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"116072","DOI":"10.1016\/j.taap.2022.116072","volume":"447","author":"Singh D.","year":"2022","unstructured":"Singh D.; Khan M.A.; Akhtar K.; Arjmand F.; Siddique H.R.; Apigenin alleviates cancer drug sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress. Toxicol Appl Pharmacol  2022,447,116072","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"9149","DOI":"10.18632\/aging.204396","volume":"14","author":"Shi C.","year":"2022","unstructured":"Shi C.; Ma C.; Ren C.; Li N.; Liu X.; Zhang Y.; Wang Y.; Li X.; Lv P.; Han C.; Li X.; LINC00629, a KLF10-responsive lncRNA, promotes the anti-cancer effects of apigenin by decreasing Mcl1 stability in oral squamous cell carcinoma. Aging  2022,14(22),9149-9166","journal-title":"Aging"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-018-0929-6","volume":"37","author":"Xu L.","year":"2018","unstructured":"Xu L.; Zhang Y.; Tian K.; Chen X.; Zhang R.; Mu X.; Wu Y.; Wang D.; Wang S.; Liu F.; Wang T.; Zhang J.; Liu S.; Zhang Y.; Tu C.; Liu H.; Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. J Exp Clin Cancer Res  2018,37(1),261","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"173810","DOI":"10.1016\/j.ejphar.2020.173810","volume":"893","author":"Pan F.","year":"2021","unstructured":"Pan F.; Zheng Y.B.; Shi C.J.; Zhang F.; Zhang J.; Fu W.; H19-Wnt\/\u03b2-catenin regulatory axis mediates the suppressive effects of apigenin on tumor growth in hepatocellular carcinoma. Eur J Pharmacol  2021,893,173810","journal-title":"Eur J Pharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.3390\/molecules27196474","volume":"27","author":"Karami A.","year":"2022","unstructured":"Karami A.; Fakhri S.; Kooshki L.; Khan H.; Polydatin: Pharmacological mechanisms, therapeutic targets, biological activities, and health benefits. Molecules  2022,27(19),6474","journal-title":"Molecules"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3109\/13880209.2013.792849","volume":"51","author":"Du Q.H.","year":"2013","unstructured":"Du Q.H.; Peng C.; Zhang H.; Polydatin: A review of pharmacology and pharmacokinetics. Pharm Biol  2013,51(11),1347-1354","journal-title":"Pharm Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.taap.2019.04.005","volume":"371","author":"Hu T.","year":"2019","unstructured":"Hu T.; Fei Z.; Su H.; Xie R.; Chen L.; Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling. Toxicol Appl Pharmacol  2019,371,55-62","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10571-018-00646-4","volume":"39","author":"Ruan W.","year":"2019","unstructured":"Ruan W.; Li J.; Xu Y.; Wang Y.; Zhao F.; Yang X.; Jiang H.; Zhang L.; Saavedra J.M.; Shi L.; Pang T.; MALAT1 up-regulator polydatin protects brain microvascular integrity and ameliorates stroke through C\/EBP\u03b2\/MALAT1\/CREB\/PGC-1\u03b1\/PPAR\u03b3 pathway. Cell Mol Neurobiol  2019,39(2),265-286","journal-title":"Cell Mol Neurobiol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.toxlet.2015.01.008","volume":"233","author":"Kasala E.R.","year":"2015","unstructured":"Kasala E.R.; Bodduluru L.N.; Madana R.M.; v A.K.; Gogoi R.; Barua C.C.; Chemopreventive and therapeutic potential of chrysin in cancer: Mechanistic perspectives. Toxicol Lett  2015,233(2),214-225","journal-title":"Toxicol Lett"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1471-4159.2010.06952.x","volume":"115","author":"Gresa-Arribas N.","year":"2010","unstructured":"Gresa-Arribas N.; Serratosa J.; Saura J.; Sol\u00e0 C.; Inhibition of CCAAT\/enhancer binding protein \u03b4 expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J Neurochem  2010,115(2),526-536","journal-title":"J Neurochem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/j.1365-2672.2011.05170.x","volume":"111","author":"Wang J.","year":"2011","unstructured":"Wang J.; Qiu J.; Dong J.; Li H.; Luo M.; Dai X.; Zhang Y.; Leng B.; Niu X.; Zhao S.; Deng X.; Chrysin protects mice from Staphylococcus aureus pneumonia. J Appl Microbiol  2011,111(6),1551-1558","journal-title":"J Appl Microbiol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.3390\/molecules27113551","volume":"27","author":"Rodr\u00edguez-Landa J.F.","year":"2022","unstructured":"Rodr\u00edguez-Landa J.F.; German-Ponciano L.J.; Puga-Olgu\u00edn A.; Olmos-V\u00e1zquez O.J.; Pharmacological, neurochemical, and behavioral mechanisms underlying the anxiolytic- and antidepressant-like effects of flavonoid chrysin. Molecules  2022,27(11),3551","journal-title":"Molecules"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3390\/ijms11052188","volume":"11","author":"Khoo B.Y.","year":"2010","unstructured":"Khoo B.Y.; Chua S.L.; Balaram P.; Apoptotic effects of chrysin in human cancer cell lines. Int J Mol Sci  2010,11(5),2188-2199","journal-title":"Int J Mol Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1016\/j.bmc.2004.09.013","volume":"12","author":"Zhang T.","year":"2004","unstructured":"Zhang T.; Chen X.; Qu L.; Wu J.; Cui R.; Zhao Y.; Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg Med Chem  2004,12(23),6097-6105","journal-title":"Bioorg Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s13193-022-01550-6","volume":"13","author":"Salari N.","year":"2022","unstructured":"Salari N.; Faraji F.; Jafarpour S.; Faraji F.; Rasoulpoor S.; Dokaneheifard S.; Mohammadi M.; Anti-cancer activity of chrysin in cancer therapy: A systematic review. Indian J Surg Oncol  2022,13(4),681-690","journal-title":"Indian J Surg Oncol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.3390\/ijms21207642","volume":"21","author":"Sherif I.O.","year":"2020","unstructured":"Sherif I.O.; Al-Mutabagani L.A.; Sabry D.; Elsherbiny N.M.; Antineoplastic activity of chrysin against human hepatocellular carcinoma: New insight on GPC3\/SULF2 axis and lncRNA-AF085935 expression. Int J Mol Sci  2020,21(20),7642","journal-title":"Int J Mol Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"651644","DOI":"10.3389\/fonc.2021.651644","volume":"11","author":"Chen L.","year":"2021","unstructured":"Chen L.; Li Q.; Jiang Z.; Li C.; Hu H.; Wang T.; Gao Y.; Wang D.; Chrysin induced cell apoptosis through H19\/let-7a\/COPB2 axis in gastric cancer cells and inhibited tumor growth. Front Oncol  2021,11,651644","journal-title":"Front Oncol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.plaphy.2021.05.023","volume":"166","author":"Singh P.","year":"2021","unstructured":"Singh P.; Arif Y.; Bajguz A.; Hayat S.; The role of quercetin in plants. Plant Physiol Biochem  2021,166,10-19","journal-title":"Plant Physiol Biochem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.3390\/ijms20133177","volume":"20","author":"Reyes-Farias M.","year":"2019","unstructured":"Reyes-Farias M.; Carrasco-Pozo C.; The anti-cancer effect of quercetin: Molecular implications in cancer metabolism. Int J Mol Sci  2019,20(13),3177","journal-title":"Int J Mol Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1039\/C4FO01178C","volume":"6","author":"Kawabata K.","year":"2015","unstructured":"Kawabata K.; Mukai R.; Ishisaka A.; Quercetin and related polyphenols: New insights and implications for their bioactivity and bioavailability. Food Funct  2015,6(5),1399-1417","journal-title":"Food Funct"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/jcb.21977","volume":"106","author":"Jeong J.H.","year":"2009","unstructured":"Jeong J.H.; An J.Y.; Kwon Y.T.; Rhee J.G.; Lee Y.J.; Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression. J Cell Biochem  2009,106(1),73-82","journal-title":"J Cell Biochem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s12032-010-9603-3","volume":"28","author":"Noori-Daloii M.R.","year":"2011","unstructured":"Noori-Daloii M.R.; Momeny M.; Yousefi M.; Shirazi F.G.; Yaseri M.; Motamed N.; Kazemialiakbar N.; Hashemi S.; Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): Implications for nutritional transcriptomics and multi-target therapy. Med Oncol  2011,28(4),1395-1404","journal-title":"Med Oncol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.enz.2015.05.001","volume":"37","author":"Shankar G.M.","year":"2015","unstructured":"Shankar G.M.; Antony J.; Anto R.J.; Quercetin and tryptanthrin. Enzymes  2015,37,43-72","journal-title":"Enzymes"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"109604","DOI":"10.1016\/j.biopha.2019.109604","volume":"121","author":"Tang S.M.","year":"2020","unstructured":"Tang S.M.; Deng X.T.; Zhou J.; Li Q.P.; Ge X.X.; Miao L.; Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother  2020,121,109604","journal-title":"Biomed Pharmacother"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12957-018-1400-z","volume":"16","author":"Ward A.B.","year":"2018","unstructured":"Ward A.B.; Mir H.; Kapur N.; Gales D.N.; Carriere P.P.; Singh S.; Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol  2018,16(1),108","journal-title":"World J Surg Oncol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.2174\/1381612826666201019102207","volume":"27","author":"Khan K.","year":"2021","unstructured":"Khan K.; Javed Z.; Sadia H.; Sharifi-Rad J.; Cho W.C.; Luparello C.; Quercetin and MicroRNA interplay in apoptosis regulation in ovarian cancer. Curr Pharm Des  2021,27(20),2328-2336","journal-title":"Curr Pharm Des"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"208","DOI":"10.22088\/IJMCM.BUMS.10.3.207","volume":"10","author":"Rezaie F.","year":"2021","unstructured":"Rezaie F.; Mokhtari M.J.; Kalani M.; Quercetin arrests in G2 phase, upregulates INXS LncRNA and downregulates UCA1 LncRNA in MCF-7 cells. Int J Mol Cell Med  2021,10(3),208-216","journal-title":"Int J Mol Cell Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/08923973.2021.1966032","volume":"43","author":"Chai R.","year":"2021","unstructured":"Chai R.; Xu C.; Lu L.; Liu X.; Ma Z.; Quercetin inhibits proliferation of and induces apoptosis in non-small-cell lung carcinoma via the lncRNA SNHG7\/miR-34a-5p pathway. Immunopharmacol Immunotoxicol  2021,43(6),693-703","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"e14230","DOI":"10.1111\/jfbc.14230","volume":"46","author":"Chandrashekar N.","year":"2022","unstructured":"Chandrashekar N.; Pandi A.; Baicalein: A review on its anti-cancer effects and mechanisms in lung carcinoma. J Food Biochem  2022,46(9),e14230","journal-title":"J Food Biochem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.biopha.2017.07.068","volume":"93","author":"Bie B.","year":"2017","unstructured":"Bie B.; Sun J.; Guo Y.; Li J.; Jiang W.; Yang J.; Huang C.; Li Z.; Baicalein: A review of its anti-cancer effects and mechanisms in hepatocellular carcinoma. Biomed Pharmacother  2017,93,1285-1291","journal-title":"Biomed Pharmacother"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3390\/cancers13061274","volume":"13","author":"Kalhori M.R.","year":"2021","unstructured":"Kalhori M.R.; Khodayari H.; Khodayari S.; Vesovic M.; Jackson G.; Farzaei M.H.; Bishayee A.; Regulation of long non-coding rnas by plant secondary metabolites: A novel anti-cancer therapeutic approach. Cancers  2021,13(6),1274","journal-title":"Cancers"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"758733","DOI":"10.3389\/fgene.2021.758733","volume":"12","author":"Fatima N.","year":"2021","unstructured":"Fatima N.; Baqri S.S.R.; Bhattacharya A.; Koney N.K.K.; Husain K.; Abbas A.; Ansari R.A.; Role of flavonoids as epigenetic modulators in cancer prevention and therapy. Front Genet  2021,12,758733","journal-title":"Front Genet"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"e8934","DOI":"10.1590\/1414-431x20198934","volume":"52","author":"Yang X.","year":"2019","unstructured":"Yang X.; Jiang J.; Zhang C.; Li Y.; Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1. Braz J Med Biol Res  2019,52(12),e8934","journal-title":"Braz J Med Biol Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.biocel.2017.11.009","volume":"94","author":"Yu X.","year":"2018","unstructured":"Yu X.; Yang Y.; Li Y.; Cao Y.; Tang L.; Chen F.; Xia J.; Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3 K\/Akt pathway. Int J Biochem Cell Biol  2018,94,107-118","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1002\/jcb.26881","volume":"119","author":"Yu X.","year":"2018","unstructured":"Yu X.; Cao Y.; Tang L.; Yang Y.; Chen F.; Xia J.; Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8-AS1-N. J Cell Biochem  2018,119(8),6842-6856","journal-title":"J Cell Biochem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbi.2018.02.027","volume":"285","author":"Yu X.","year":"2018","unstructured":"Yu X.; Tang W.; Yang Y.; Tang L.; Dai R.; Pu B.; Feng C.; Xia J.; Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-\u03baB signaling. Chem Biol Interact  2018,285,48-58","journal-title":"Chem Biol Interact"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"e20200574","DOI":"10.1590\/0001-3765202020200574","volume":"92","author":"Mostafa S.M.","year":"2020","unstructured":"Mostafa S.M.; Gamal-Eldeen A.M.; Maksoud N.A.E.; Fahmi A.A.; Epigallocatechin gallate-capped gold nanoparticles enhanced the tumor suppressors let-7a and miR-34a in hepatocellular carcinoma cells. An Acad Bras Cienc  2020,92(4),e20200574","journal-title":"An Acad Bras Cienc"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"165856","DOI":"10.1016\/j.bbadis.2020.165856","volume":"1866","author":"Zhao Y.","year":"2020","unstructured":"Zhao Y.; Chen X.; Jiang J.; Wan X.; Wang Y.; Xu P.; Epigallocatechin gallate reverses gastric cancer by regulating the long noncoding RNA LINC00511\/miR-29b\/KDM2A axis. Biochim Biophys Acta Mol Basis Dis  2020,1866(10),165856","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/mmr.2019.9816","volume":"19","author":"Hu D.L.","year":"2019","unstructured":"Hu D.L.; Wang G.; Yu J.; Zhang L.H.; Huang Y.F.; Wang D.; Zhou H.H.; Epigallocatechin-3-gallate modulates long non-coding RNA and mRNA expression profiles in lung cancer cells. Mol Med Rep  2019,19(3),1509-1520","journal-title":"Mol Med Rep"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s11033-019-04653-6","volume":"46","author":"Sabry D.","year":"2019","unstructured":"Sabry D.; Abdelaleem O.O.; El Amin Ali A.M.; Mohammed R.A.; Abdel-Hameed N.D.; Hassouna A.; Khalifa W.A.; Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and\/or metformin on hepatocellular carcinoma cells: In vitro study. Mol Biol Rep  2019,46(2),2039-2047","journal-title":"Mol Biol Rep"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0366-6999.147824","volume":"128","author":"Liu G.","year":"2015","unstructured":"Liu G.; Zheng X.; Xu Y.; Lu J.; Chen J.; Huang X.; Long non-coding RNAs expression profile in HepG2 cells reveals the potential role of long non-coding RNAs in the cholesterol metabolism. Chin Med J  2015,128(1),91-97","journal-title":"Chin Med J"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.3390\/antiox11122352","volume":"11","author":"Hayakawa S.","year":"2022","unstructured":"Hayakawa S.; Ohishi T.; Oishi Y.; Isemura M.; Miyoshi N.; Contribution of non-coding RNAs to anti-cancer effects of dietary polyphenols: chlorogenic acid, curcumin, epigallocatechin-3-gallate, genistein, quercetin and resveratrol. Anti-oxidants  2022,11(12),2352","journal-title":"Anti-oxidants"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"318","DOI":"10.14715\/cmb\/2021.67.6.42","volume":"67","author":"Mobeen I.","year":"2022","unstructured":"Mobeen I.; Romero M.A.; Yulaevna I.M.; Attar R.; Jabeen S.; Fayyaz S.; Regulation of cell signaling pathways by genistein in different cancers: Progress, prospects and pitfalls. Cell Mol Biol  2022,67(6),318-329","journal-title":"Cell Mol Biol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/biof.1627","volume":"46","author":"Chen X.","year":"2020","unstructured":"Chen X.; Wu Y.; Gu J.; Liang P.; Shen M.; Xi J.; Qin J.; Anti-invasive effect and pharmacological mechanism of genistein against colorectal cancer. Biofactors  2020,46(4),620-628","journal-title":"Biofactors"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/804510","volume":"2014","author":"Phuah N.H.","year":"2014","unstructured":"Phuah N.H.; Nagoor N.H.; Regulation of microRNAs by natural agents: New strategies in cancer therapies. BioMed Res Int  2014,2014,1-17","journal-title":"BioMed Res Int"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1159\/000369732","volume":"35","author":"Chen J.","year":"2015","unstructured":"Chen J.; Lin C.; Yong W.; Ye Y.; Huang Z.; Calycosin and genistein induce apoptosis by inactivation of HOTAIR\/p-Akt signaling pathway in human breast cancer MCF-7 cells. Cell Physiol Biochem  2015,35(2),722-728","journal-title":"Cell Physiol Biochem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"e70372","DOI":"10.1371\/journal.pone.0070372","volume":"8","author":"Chiyomaru T.","year":"2013","unstructured":"Chiyomaru T.; Yamamura S.; Fukuhara S.; Yoshino H.; Kinoshita T.; Majid S.; Saini S.; Chang I.; Tanaka Y.; Enokida H.; Seki N.; Nakagawa M.; Dahiya R.; Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One  2013,8(8),e70372","journal-title":"PLoS One"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"111350","DOI":"10.1016\/j.biopha.2021.111350","volume":"138","author":"Chen Y.","year":"2021","unstructured":"Chen Y.; Zhu Z.; Chen J.; Zheng Y.; Limsila B.; Lu M.; Gao T.; Yang Q.; Fu C.; Liao W.; Terpenoids from Curcumae Rhizoma: Their anti-cancer effects and clinical uses on combination and versus drug therapies. Biomed Pharmacother  2021,138,111350","journal-title":"Biomed Pharmacother"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"108812","DOI":"10.1016\/j.biopha.2019.108812","volume":"114","author":"Zhai B.","year":"2019","unstructured":"Zhai B.; Zhang N.; Han X.; Li Q.; Zhang M.; Chen X.; Li G.; Zhang R.; Chen P.; Wang W.; Li C.; Xiang Y.; Liu S.; Duan T.; Lou J.; Xie T.; Sui X.; Molecular targets of \u03b2-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review. Biomed Pharmacother  2019,114,108812","journal-title":"Biomed Pharmacother"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/CAD.0000000000000216","volume":"26","author":"Hu Z.","year":"2015","unstructured":"Hu Z.; Wu H.; Li Y.; Hou Q.; Wang Y.; Li S.; Xia B.; Wu S.; \u03b2-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression. Anti-cancer Drugs  2015,26(5),531-539","journal-title":"Anti-cancer Drugs"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"BSR20190804","DOI":"10.1042\/BSR20190804","volume":"40","author":"Hu T.","year":"2020","unstructured":"Hu T.; Gao Y.; \u03b2-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway. Biosci Rep  2020,40(2),BSR20190804","journal-title":"Biosci Rep"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"106739","DOI":"10.1016\/j.phrs.2023.106739","volume":"191","author":"Xu C.","year":"2023","unstructured":"Xu C.; Jiang Z.B.; Shao L.; Zhao Z.M.; Fan X.X.; Sui X.; Yu L.L.; Wang X.R.; Zhang R.N.; Wang W.J.; Xie Y.J.; Zhang Y.Z.; Nie X.W.; Xie C.; Huang J.M.; Wang J.; Wang J.; Leung E.L.H.; Wu Q.B.; \u03b2-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. Pharmacol Res  2023,191,106739","journal-title":"Pharmacol Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","volume":"24","author":"Zhu L.","year":"2019","unstructured":"Zhu L.; Chen L.; Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett  2019,24(1),40","journal-title":"Cell Mol Biol Lett"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S1875-5364(20)60032-2","volume":"18","author":"Yang Y.H.","year":"2020","unstructured":"Yang Y.H.; Mao J.W.; Tan X.L.; Research progress on the source, production, and anti-cancer mechanisms of paclitaxel. Chin J Nat Med  2020,18(12),890-897","journal-title":"Chin J Nat Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2174\/1381612829666221102155212","volume":"28","author":"Thiruvengadam M.","year":"2022","unstructured":"Thiruvengadam M.; Ahmed Khalil A.; Rauf A.; Alhumaydhi F.A.; Aljohani A.S.M.; Javed M.S.; Khan M.A.; Khan I.A.; El-Esawi M.A.; Bawazeer S.; Bouyahya A.; Rebezov M.; Shariati M.A.; Recent developments and anti-cancer therapeutics of paclitaxel: An update. Curr Pharm Des  2022,28(41),3363-3373","journal-title":"Curr Pharm Des"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nbt.2014.02.010","volume":"31","author":"Howat S.","year":"2014","unstructured":"Howat S.; Park B.; Oh I.S.; Jin Y.W.; Lee E.K.; Loake G.J.; Paclitaxel: Biosynthesis, production and future prospects. N Biotechnol  2014,31(3),242-245","journal-title":"N Biotechnol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2217\/pgs.10.32","volume":"11","author":"Rodr\u00edguez-Antona C.","year":"2010","unstructured":"Rodr\u00edguez-Antona C.; Pharmacogenomics of paclitaxel. Pharmacogenomics  2010,11(5),621-623","journal-title":"Pharmacogenomics"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/DDDT.S56801","volume":"8","author":"Dong Z.","year":"2014","unstructured":"Dong Z.; Zhang D.; Yang R.; Wang S.; Paclitaxel: New uses for an old drug. Drug Des Devel Ther  2014,8,279-284","journal-title":"Drug Des Devel Ther"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"591","DOI":"10.26355\/eurrev_202001_20035","volume":"24","author":"Li Z-Y.","year":"2020","unstructured":"Li Z-Y.; Wang X-L.; Dang Y.; Zhu X-Z.; Zhang Y-H.; Cai B-X.; Zheng L.; Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p\/SIK2 axis. Eur Rev Med Pharmacol Sci  2020,24(2),591-603","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/cbr.2019.3363","volume":"36","author":"Zhao Y.","year":"2021","unstructured":"Zhao Y.; Hong L.; lncRNA-PRLB confers paclitaxel resistance of ovarian cancer cells by regulating RSF1\/NF-\u03baB signaling pathway. Cancer Biother Radiopharm  2021,36(2),202-210","journal-title":"Cancer Biother Radiopharm"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1111\/jcmm.13679","volume":"22","author":"Wang R.","year":"2018","unstructured":"Wang R.; Zhang T.; Yang Z.; Jiang C.; Seng J.; Long non-coding  1P3 activates paclitaxel resistance in breast cancer through miR-206\/  1. J Cell Mol Med  2018,22(9),4068-4075","journal-title":"J Cell Mol Med"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12906-017-2062-z","volume":"18","author":"Haroyan A.","year":"2018","unstructured":"Haroyan A.; Mukuchyan V.; Mkrtchyan N.; Minasyan N.; Gasparyan S.; Sargsyan A.; Narimanyan M.; Hovhannisyan A.; Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: A comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med  2018,18(1),7","journal-title":"BMC Complement Altern Med"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1055\/s-2006-947227","volume":"72","author":"Ammon H.","year":"2006","unstructured":"Ammon H.; Boswellic acids in chronic inflammatory diseases. Planta Med  2006,72(12),1100-1116","journal-title":"Planta Med"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1016\/0006-2952(89)90124-X","volume":"38","author":"Reddy G.K.","year":"1989","unstructured":"Reddy G.K.; Chandrakasan G.; Dhar S.C.; Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem Pharmacol  1989,38(20),3527-3534","journal-title":"Biochem Pharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/ijc.26251","volume":"130","author":"Yadav V.R.","year":"2012","unstructured":"Yadav V.R.; Prasad S.; Sung B.; Gelovani J.G.; Guha S.; Krishnan S.; Aggarwal B.B.; Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int J Cancer  2012,130(9),2176-2184","journal-title":"Int J Cancer"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/carcin\/23.12.2087","volume":"23","author":"Liu J.J.","year":"2002","unstructured":"Liu J.J.; Nilsson A.; Oredsson S.; Badmaev V.; Zhao W.Z.; Duan R.D.; Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas\/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis  2002,23(12),2087-2093","journal-title":"Carcinogenesis"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"660","DOI":"10.7150\/ijbs.19194","volume":"13","author":"Dai J.","year":"2017","unstructured":"Dai J.; Lin Y.; Duan Y.; Li Z.; Zhou D.; Chen W.; Wang L.; Zhang Q.Q.; Andrographolide inhibits angiogenesis by inhibiting the Mir-21-5p\/TIMP3 signaling pathway. Int J Biol Sci  2017,13(5),660-668","journal-title":"Int J Biol Sci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.2147\/CMAR.S238051","volume":"12","author":"Jiang X.","year":"2020","unstructured":"Jiang X.; Liu Y.; Zhang G.; Lin S.; Yuan N.; Wu J.; Yan X.; Ma Y.; Ma M.; Acetyl-11-keto-\u03b2-boswellic acid inhibits precancerous breast lesion MCF-10AT cells via regulation of LINC00707\/miR-206 that reduces estrogen receptor-\u03b1. Cancer Manag Res  2020,12,2301-2314","journal-title":"Cancer Manag Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3892\/ijmm.2017.2857","volume":"39","author":"Sun M.","year":"2017","unstructured":"Sun M.; Ye Y.; Xiao L.; Duan X.; Zhang Y.; Zhang H.; Anti-cancer effects of ginsenoside Rg3 (Review). Int J Mol Med  2017,39(3),507-518","journal-title":"Int J Mol Med"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"575","DOI":"10.18388\/abp.2020_5343","volume":"68","author":"Zhao L.","year":"2021","unstructured":"Zhao L.; Sun W.; Zheng A.; Zhang Y.; Fang C.; Zhang P.; Ginsenoside Rg3 suppresses ovarian cancer cell proliferation and invasion by inhibiting the expression of lncRNA H19. Acta Biochim Pol  2021,68(4),575-582","journal-title":"Acta Biochim Pol"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12950-021-00296-2","volume":"18","author":"Wu P.","year":"2021","unstructured":"Wu P.; Yu X.; Peng Y.; Wang Q.L.; Deng L.T.; Xing W.; Ginsenoside Rg3 alleviates septic liver injury by regulating the lncRNA TUG1\/miR-200c-3p\/SIRT1 axis. J Inflamm  2021,18(1),31","journal-title":"J Inflamm"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1080\/21655979.2021.1932211","volume":"12","author":"Pu Z.","year":"2021","unstructured":"Pu Z.; Ge F.; Wang Y.; Jiang Z.; Zhu S.; Qin S.; Dai Q.; Liu H.; Hua H.; Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. Bioengineered  2021,12(1),2398-2409","journal-title":"Bioengineered"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41523-022-00402-4","volume":"8","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Lu Q.; Li N.; Xu M.; Miyamoto T.; Liu J.; Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF\/MEK\/ERK pathway. NPJ Breast Cancer  2022,8(1),40","journal-title":"NPJ Breast Cancer"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/jmf.2018.0024","volume":"22","author":"Vanduchova A.","year":"2019","unstructured":"Vanduchova A.; Anzenbacher P.; Anzenbacherova E.; Isothiocyanate from broccoli, sulforaphane, and its properties. J Med Food  2019,22(2),121-126","journal-title":"J Med Food"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/cancers13040827","volume":"13","author":"Luo Y.","year":"2021","unstructured":"Luo Y.; Yan B.; Liu L.; Yin L.; Ji H.; An X.; Gladkich J.; Qi Z.; De La Torre C.; Herr I.; Sulforaphane inhibits the expression of long noncoding RNA H19 and Its Target APOBEC3G and thereby pancreatic cancer progression. Cancers  2021,13(4),827","journal-title":"Cancers"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jnutbio.2017.01.001","volume":"42","author":"Beaver L.M.","year":"2017","unstructured":"Beaver L.M.; Kuintzle R.; Buchanan A.; Wiley M.W.; Glasser S.T.; Wong C.P.; Johnson G.S.; Chang J.H.; L\u00f6hr C.V.; Williams D.E.; Dashwood R.H.; Hendrix D.A.; Ho E.; Long noncoding RNAs and sulforaphane: A target for chemoprevention and suppression of prostate cancer. J Nutr Biochem  2017,42,72-83","journal-title":"J Nutr Biochem"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-3-319-13374-4_5","author":"Stanojkovi\u0107 T.","year":"2015","unstructured":"Stanojkovi\u0107 T.; Investigations of lichen secondary metabolites with potential anti-cancer activity. Lichen Secondary Metabolites  2015,127-146","journal-title":"Lichen Secondary Metabolites"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12210-021-01044-7","volume":"33","author":"\u00c7olak B.","year":"2022","unstructured":"\u00c7olak B.; Cansaran-Duman D.; Guney Eskiler G.; F\u00f6ldes K.; Yang\u0131n S.; Usnic acid-induced programmed cell death in ovarian cancer cells. Rend Lincei Sci Fis Nat  2022,33(1),143-152","journal-title":"Rend Lincei Sci Fis Nat"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10456-012-9270-4","volume":"15","author":"Song Y.","year":"2012","unstructured":"Song Y.; Dai F.; Zhai D.; Dong Y.; Zhang J.; Lu B.; Luo J.; Liu M.; Yi Z.; Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1\/2 signaling pathways. Angiogenesis  2012,15(3),421-432","journal-title":"Angiogenesis"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2174\/1871520618666181112120142","volume":"19","author":"Kili\u00e7 N.","year":"2019","unstructured":"Kili\u00e7 N.; Islako\u011flu Y.\u00d6.; B\u00fcy\u00fck \u0130.; G\u00fcr-Dedeo\u011flu B.; Cansaran-Duman D.; Determination of usnic acid responsive mirnas in breast cancer cell lines. Anti-cancer Agents Med Chem  2019,19(12),1463-1472","journal-title":"Anti-cancer Agents Med Chem"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"29219","DOI":"10.3390\/ijms161226160","volume":"16","author":"Petrozza V.","year":"2015","unstructured":"Petrozza V.; Carbone A.; Bellissimo T.; Porta N.; Palleschi G.; Pastore A.; Di Carlo A.; Della Rocca C.; Fazi F.; Oncogenic MicroRNAs characterization in clear cell renal cell carcinoma. Int J Mol Sci  2015,16(12),29219-29225","journal-title":"Int J Mol Sci"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/iub.1273","volume":"66","author":"Wang B.","year":"2014","unstructured":"Wang B.; Li J.; Sun M.; Sun L.; Zhang X.; MiRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. IUBMB Life  2014,66(5),371-377","journal-title":"IUBMB Life"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ijc.29544","volume":"137","author":"Wen Y.","year":"2015","unstructured":"Wen Y.; Han J.; Chen J.; Dong J.; Xia Y.; Liu J.; Jiang Y.; Dai J.; Lu J.; Jin G.; Han J.; Wei Q.; Shen H.; Sun B.; Hu Z.; Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Int J Cancer  2015,137(7),1679-1690","journal-title":"Int J Cancer"},{"key":"ref=166","first-page":"28","volume":"1","author":"Secme M.","year":"2021","unstructured":"Secme M.; Dodurga Y.; Usnic acid inhibits cell proliferation and downregulates LncRNA UCA1 expression in ishikawa endometrial cancer cells. Nat Prod Biotechnol  2021,1(1),28-37","journal-title":"Nat Prod Biotechnol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1134\/S0026893317050247","volume":"51","author":"Zinovieva O.L.","year":"2017","unstructured":"Zinovieva O.L.; Grineva E.N.; Prokofjeva M.M.; Karpov D.S.; Krasnov G.S.; Prassolov V.S.; Mashkova T.D.; Lisitsyn N.A.; Treatment with anti-cancer agents results in profound changes in lncRNA expression in colon cancer cells. Mol Biol  2017,51(5),733-739","journal-title":"Mol Biol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1050032","DOI":"10.3389\/fphar.2022.1050032","volume":"13","author":"Sung W.J.","year":"2023","unstructured":"Sung W.J.; Hong J.; Targeting lncRNAs of colorectal cancers with natural products. Front Pharmacol  2023,13,1050032","journal-title":"Front Pharmacol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nsmb.2844","volume":"21","author":"Brown J.A.","year":"2014","unstructured":"Brown J.A.; Bulkley D.; Wang J.; Valenstein M.L.; Yario T.A.; Steitz T.A.; Steitz J.A.; Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat Struct Mol Biol  2014,21(7),633-640","journal-title":"Nat Struct Mol Biol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3390\/cancers15123135","volume":"15","author":"Gencel-Augusto J.","year":"2023","unstructured":"Gencel-Augusto J.; Wu W.; Bivona T.G.; Long non-coding RNAs as emerging targets in lung cancer. Cancers  2023,15(12),3135","journal-title":"Cancers"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.omtn.2022.09.016","volume":"30","author":"Rakheja I.","year":"2022","unstructured":"Rakheja I.; Ansari A.H.; Ray A.; Chandra Joshi D.; Maiti S.; Small molecule quercetin binds MALAT1 triplex and modulates its cellular function. Mol Ther Nucleic Acids  2022,30,241-256","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-022-04537-z","volume":"604","author":"Aguilar R.","year":"2022","unstructured":"Aguilar R.; Spencer K.B.; Kesner B.; Rizvi N.F.; Badmalia M.D.; Mrozowich T.; Mortison J.D.; Rivera C.; Smith G.F.; Burchard J.; Dandliker P.J.; Patel T.R.; Nickbarg E.B.; Lee J.T.; Targeting Xist with compounds that disrupt RNA structure and X inactivation. Nature  2022,604(7904),160-166","journal-title":"Nature"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673264372230919102758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/222792\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673264372230919102758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T09:39:35Z","timestamp":1733737175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/222792\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":172,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673264372230919102758","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}